ER Heart Risk Check for Cholesterol Study
Treatments studied
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial tests a new way to check heart risk and start treatment for cholesterol in people coming to the emergency room with chest pain or possible heart attack. It aims to see if early risk assessment and treatment can prevent future heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old and currently being evaluated for possible heart attack symptoms.
- Your 10-year risk of a heart-related event is 7.5% or higher, or you have diabetes, or you have had a previous heart attack, stroke, or artery disease.
- You cannot be taking any cholesterol-lowering medication (statins, Zetia, PCSK9 inhibitors, etc.) at the start.
- You must be able to return for a follow-up visit after 30 days.
- You must not be pregnant, on dialysis, have liver cirrhosis, or have unstable vital signs (like low blood pressure or high heart rate).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to talk with people about their heart health after they come to the Emergency Room with chest pain. It aims to help you understand your risk and what you can do to prevent future problems.
This study tests whether quickly increasing cholesterol-lowering medication can reduce the risk of another heart attack or stroke. It is for people who have heart disease from blocked arteries.
This trial compares two very low LDL-cholesterol targets (below 1.0 vs 1.0-1.39 mmol/L) using extra medications (PCSK9 inhibitors) to see which is safer and better for people at extremely high risk of heart attacks or strokes.
This study tests whether an educational program can help people with high cholesterol and heart disease get their LDL cholesterol levels lower. It involves watching online videos and working with your doctor to adjust treatments.
This study tests an educational program to help people understand and lower their LDL ('bad') cholesterol after a heart-related event. It aims to improve awareness and encourage the use of cholesterol-lowering treatments.
This study tests whether adding an extra cholesterol-lowering drug (bempedoic acid) to the usual treatment soon after a heart attack or related event can lower 'bad' cholesterol more effectively. It may help reduce the risk of future heart problems.
Hear when a new Lipid Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.